Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Telehealth with remote blood pressure monitoring for postpartum hypertension: A prospective single-cohort feasibility study.

Hoppe KK, Williams M, Thomas N, Zella JB, Drewry A, Kim K, Havighurst T, Johnson HM.

Pregnancy Hypertens. 2019 Jan;15:171-176. doi: 10.1016/j.preghy.2018.12.007. Epub 2018 Dec 31.

PMID:
30825917
2.

Proproliferative function of adaptor protein GRB10 in prostate carcinoma.

Khan MI, Al Johani A, Hamid A, Ateeq B, Manzar N, Adhami VM, Lall RK, Rath S, Sechi M, Siddiqui IA, Choudhry H, Zamzami MA, Havighurst TC, Huang W, Ntambi JM, Mukhtar H.

FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31.

PMID:
30379590
3.

Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers.

Scrima AT, Lubner MG, Abel EJ, Havighurst TC, Shapiro DD, Huang W, Pickhardt PJ.

Abdom Radiol (NY). 2019 Jun;44(6):1999-2008. doi: 10.1007/s00261-018-1649-2.

PMID:
29804215
4.

Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAFV600E inhibitors.

Kim T, Havighurst T, Kim K, Albertini M, Xu YG, Spiegelman VS.

Mol Carcinog. 2018 May;57(5):678-683. doi: 10.1002/mc.22786. Epub 2018 Feb 5.

5.

A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, House MG, Parnes HL, Bailey HH.

Cancer Prev Res (Phila). 2017 May;10(5):298-307. doi: 10.1158/1940-6207.CAPR-16-0167. Epub 2017 Mar 21.

6.

RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma.

Kim T, Havighurst T, Kim K, Hebbring SJ, Ye Z, Aylward J, Keles S, Xu YG, Spiegelman VS.

J Invest Dermatol. 2017 Mar;137(3):772-775. doi: 10.1016/j.jid.2016.10.042. Epub 2016 Nov 14. No abstract available.

7.

Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

Jarrard D, Konety B, Huang W, Downs T, Kolesar J, Kim KM, Havighurst T, Slaton J, House MG, Parnes HL, Bailey HH.

Am J Clin Exp Urol. 2016 Sep 20;4(2):17-27. eCollection 2016.

8.

Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.

Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, Gong S, Xu W.

Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27.

9.

Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.

Chang JE, Havighurst T, Kim K, Eickhoff J, Traynor AM, Kirby-Slimp R, Volk LM, Werndli J, Go RS, Weiss M, Blank J, Kahl BS.

Br J Haematol. 2016 Apr;173(2):283-91. doi: 10.1111/bjh.13957. Epub 2016 Feb 23.

10.

Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.

Singh A, Singh A, Bauer SJ, Wheeler DL, Havighurst TC, Kim K, Verma AK.

Carcinogenesis. 2016 Jan;37(1):72-80. doi: 10.1093/carcin/bgv162. Epub 2015 Nov 19.

11.

Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Fabian CJ, Kimler BF, Zalles CM, Phillips TA, Metheny T, Petroff BK, Havighurst TC, Kim K, Bailey HH, Heckman-Stoddard BM.

Cancer Prev Res (Phila). 2015 Dec;8(12):1146-55. doi: 10.1158/1940-6207.CAPR-15-0109. Epub 2015 Sep 21.

12.

Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.

Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH.

Eur J Cancer Prev. 2016 Jul;25(4):312-20. doi: 10.1097/CEJ.0000000000000189.

PMID:
26313229
13.

Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model.

Singh CK, Ndiaye MA, Siddiqui IA, Nihal M, Havighurst T, Kim K, Zhong W, Mukhtar H, Ahmad N.

Oncotarget. 2014 Jun 15;5(11):3651-61.

14.

Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.

Kolesar JM, Pomplun M, Havighurst T, Stublaski J, Wollmer B, Kim K, Tangrea JA, Parnes HL, House MG, Gee J, Messing E, Bailey HH.

J Oncol Pharm Pract. 2015 Apr;21(2):128-31. doi: 10.1177/1078155214528552. Epub 2014 Mar 17.

15.

Intensity of physical activity in the energy expenditure of older adults.

Colbert LH, Matthews CE, Schoeller DA, Havighurst TC, Kim K.

J Aging Phys Act. 2014 Oct;22(4):571-7. doi: 10.1123/japa.2012-0257. Epub 2013 Dec 4.

16.

α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model.

Hafeez BB, Mustafa A, Fischer JW, Singh A, Zhong W, Shekhani MO, Meske L, Havighurst T, Kim K, Verma AK.

Antioxid Redox Signal. 2014 Aug 10;21(5):682-99. doi: 10.1089/ars.2013.5212. Epub 2014 Feb 6.

17.

Predictors of willingness to participate in window-of-opportunity breast trials.

Wisinski KB, Faerber A, Wagner S, Havighurst TC, McElroy JA, Kim K, Bailey HH.

Clin Med Res. 2013 Sep;11(3):107-12. doi: 10.3121/cmr.2013.1136. Epub 2013 Apr 11.

18.

Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G.

Prostate. 2013 Jun;73(9):970-8. doi: 10.1002/pros.22644. Epub 2013 Jan 17.

19.

Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.

Hafeez BB, Zhong W, Fischer JW, Mustafa A, Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim K, Verma AK.

Mol Oncol. 2013 Jun;7(3):428-39. doi: 10.1016/j.molonc.2012.12.001. Epub 2012 Dec 14.

20.

A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.

Kreul SM, Havighurst T, Kim K, Mendonça EA, Wood GS, Snow S, Borich A, Verma A, Bailey HH.

Cancer Prev Res (Phila). 2012 Dec;5(12):1368-74. doi: 10.1158/1940-6207.CAPR-12-0233. Epub 2012 Oct 11.

21.

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, Kolesar J, Harris L, Faerber A, Havighurst T, Young JM, Efros M, Getzenberg RH, Wheeler MA, Tangrea J, Parnes H, House M, Busby JE, Hohl R, Bailey H.

Cancer Prev Res (Phila). 2012 Apr;5(4):621-30. doi: 10.1158/1940-6207.CAPR-11-0455. Epub 2012 Jan 31.

22.

A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteers.

Kolesar JM, Hoel R, Pomplun M, Havighurst T, Stublaski J, Wollmer B, Krontiras H, Brouillette W, Muccio D, Kim K, Grubbs CJ, Bailey HE.

Cancer Prev Res (Phila). 2010 Dec;3(12):1565-70. doi: 10.1158/1940-6207.CAPR-10-0149.

23.

Comparative validity of physical activity measures in older adults.

Colbert LH, Matthews CE, Havighurst TC, Kim K, Schoeller DA.

Med Sci Sports Exerc. 2011 May;43(5):867-76. doi: 10.1249/MSS.0b013e3181fc7162.

24.

TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells.

Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, Kim K, Wang JK, Antalis TM, Johnson MD, Lin CY.

Am J Pathol. 2010 Jun;176(6):2986-96. doi: 10.2353/ajpath.2010.090665. Epub 2010 Apr 9.

25.

Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF.

Maddodi N, Huang W, Havighurst T, Kim K, Longley BJ, Setaluri V.

J Invest Dermatol. 2010 Jun;130(6):1657-67. doi: 10.1038/jid.2010.26. Epub 2010 Feb 25.

26.

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, Lenaghan T, Viner JL, Douglas J, Dreckschmidt NE, Hamielec M, Pomplun M, Sharata HH, Puchalsky D, Berg ER, Havighurst TC, Carbone PP.

Cancer Prev Res (Phila). 2010 Jan;3(1):35-47. doi: 10.1158/1940-6207.CAPR-09-0096.

27.

Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.

Gee JR, Burmeister CB, Havighurst TC, Kim K.

Anticancer Res. 2009 Oct;29(10):3769-75.

28.

Brief report: Measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine.

Jensen ME, Hartenbach E, McElroy JA, Faerber A, Havighurst T, Kim KM, Bailey HH.

WMJ. 2009 Jul;108(4):203-5.

29.

PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas.

Sand JM, Aziz MH, Dreckschmidt NE, Havighurst TC, Kim K, Oberley TD, Verma AK.

J Invest Dermatol. 2010 Jan;130(1):270-7. doi: 10.1038/jid.2009.212.

30.

Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors.

Adams WM, Kleiter MM, Thrall DE, Klauer JM, Forrest LJ, La Due TA, Havighurst TC.

Vet Radiol Ultrasound. 2009 May-Jun;50(3):330-5.

PMID:
19507402
31.

Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.

Hutson PR, Love RR, Havighurst TC, Rogers E, Cleary JF.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8722-7.

32.

Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer.

Love RR, Hutson PR, Havighurst TC, Cleary JF.

Clin Cancer Res. 2005 Feb 15;11(4):1500-3.

33.

Duration of signs and survival in premenopausal women with breast cancer.

Love RR, Duc NB, Baumann LC, Anh PT, To TV, Qian Z, Havighurst TC.

Breast Cancer Res Treat. 2004 Jul;86(2):117-24.

PMID:
15319564
34.

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study.

Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh le D, To TV, Qian Z, Love RR, Allred DC.

Mod Pathol. 2004 Dec;17(12):1545-54. Erratum in: Mod Pathol. 2005 Mar;18(3):461. Qian, Zho [corrected to Qian, Zhang].

35.

Dietary restriction and beta-cell sensitivity to glucose in adult male rhesus monkeys.

Gresl TA, Colman RJ, Havighurst TC, Allison DB, Schoeller DA, Kemnitz JW.

J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):598-610.

PMID:
12865475
36.

Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer.

Love RR, Astrow SH, Cheeks AM, Havighurst TC.

Breast Cancer Res Treat. 2003 Jun;79(3):329-34.

PMID:
12846417
37.

Insulin sensitivity and glucose effectiveness from three minimal models: effects of energy restriction and body fat in adult male rhesus monkeys.

Gresl TA, Colman RJ, Havighurst TC, Byerley LO, Allison DB, Schoeller DA, Kemnitz JW.

Am J Physiol Regul Integr Comp Physiol. 2003 Dec;285(6):R1340-54. Epub 2003 Jul 3.

38.

Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study.

Love RR, Ba Duc N, Cong Binh N, Mahler PA, Thomadsen BR, Hong Long N, Shen TZ, Havighurst TC.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):697-703.

PMID:
12788175
39.

Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer.

Love RR, Duc NB, Havighurst TC, Mohsin SK, Zhang Q, DeMets DL, Allred DC.

J Clin Oncol. 2003 Feb 1;21(3):453-7.

PMID:
12560434
40.

Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.

Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh le D, Khang HX, Tran TL, Quy TT, Thuy NV, Thé PN, Cau TT, Tung ND, Huong DT, Quang le M, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL.

J Clin Oncol. 2002 May 15;20(10):2559-66.

PMID:
12011136
41.

Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.

Love RR, Duc NB, Dinh NV, Shen TZ, Havighurst TC, Allred DC, DeMets DL.

J Natl Cancer Inst. 2002 May 1;94(9):662-9.

PMID:
11983754
42.

Young age as an adverse prognostic factor in premenopausal women with operable breast cancer.

Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC.

Clin Breast Cancer. 2002 Jan;2(4):294-8.

PMID:
11899361
43.

Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr.

Gresl TA, Colman RJ, Roecker EB, Havighurst TC, Huang Z, Allison DB, Bergman RN, Kemnitz JW.

Am J Physiol Endocrinol Metab. 2001 Oct;281(4):E757-65.

44.

Problems of older adults living alone after hospitalization.

Mahoney JE, Eisner J, Havighurst T, Gray S, Palta M.

J Gen Intern Med. 2000 Sep;15(9):611-9.

45.

Sleep apnea and quality of life.

Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S.

Sleep. 2000 Jun 15;23(4):535-41.

PMID:
10875560
46.

Symptoms associated with oophorectomy and tamoxifen treatment for breast cancer in premenopausal Vietnamese women.

Love RR, Nguyen BD, Nguyen CB, Nguyen VD, Havighurst TC.

Breast Cancer Res Treat. 1999 Dec;58(3):281-6.

PMID:
10718489
47.

Body fat distribution with long-term dietary restriction in adult male rhesus macaques.

Colman RJ, Ramsey JJ, Roecker EB, Havighurst T, Hudson JC, Kemnitz JW.

J Gerontol A Biol Sci Med Sci. 1999 Jul;54(7):B283-90.

PMID:
10462160
48.

Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years.

Love RR, Olsen MR, Havighurst TC.

J Natl Cancer Inst. 1999 Jul 7;91(13):1167-8. No abstract available.

PMID:
10393732
49.

Correlation of serum L-carnitine and dehydro-epiandrosterone sulphate levels with age and sex in healthy adults.

Chiu KM, Schmidt MJ, Havighurst TC, Shug AL, Daynes RA, Keller ET, Gravenstein S.

Age Ageing. 1999 Mar;28(2):211-6.

PMID:
10350421
50.

Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection.

Kent-First M, Muallem A, Shultz J, Pryor J, Roberts K, Nolten W, Meisner L, Chandley A, Gouchy G, Jorgensen L, Havighurst T, Grosch J.

Mol Reprod Dev. 1999 May;53(1):27-41.

PMID:
10230814

Supplemental Content

Loading ...
Support Center